Certified Lactation Specialist Adverse Event Reporting 3 — Questions and Answers
Question 1: A breastfeeding mother experienced severe sedation after taking an herbal galactagogue supplement. Since herbal supplements are regulated as dietary supplements, the adverse event should be reported to:
- The DEA (Drug Enforcement Administration)
- FDA via the Safety Reporting Portal under dietary supplement AE reporting (Correct answer)
- OSHA (Occupational Safety and Health Administration)
- The American Herbal Products Association only
Correct answer: FDA via the Safety Reporting Portal under dietary supplement AE reporting
Dietary supplement adverse events are reported to the FDA through its Safety Reporting Portal; the FDA oversees supplement safety post-market.
Question 2: An infant develops apnea episodes after the mother takes a high-dose fenugreek supplement to boost milk supply. The lactation consultant should document this as which type of adverse event?
- A maternal adverse event only
- A neonatal adverse event secondary to maternal exposure (Correct answer)
- A product liability issue outside the scope of lactation care
- An expected pharmacological effect requiring no special reporting
Correct answer: A neonatal adverse event secondary to maternal exposure
When maternal supplement use leads to infant symptoms via breast milk transfer, the adverse event is classified as neonatal/pediatric, secondary to maternal exposure, and should be reported accordingly.
Question 3: Which timeline does the FDA require for mandatory expedited reporting of unexpected serious adverse events for regulated clinical trials involving lactating participants?
- 30 calendar days
- 15 calendar days (Correct answer)
- 7 calendar days
- 60 calendar days
Correct answer: 15 calendar days
The FDA mandates expedited (15 calendar day) reporting for unexpected serious adverse events in regulated clinical investigations.
Question 4: A lactation consultant suspects that a newly marketed nipple shield caused nipple tissue necrosis in a patient. The consultant cannot identify the manufacturer. What is the best next step?
- Decline to report because the manufacturer is unknown
- Contact FDA MedWatch, providing all available product details; FDA will investigate the manufacturer (Correct answer)
- Wait until the manufacturer is identified before filing
- Report only to the hospital risk management team
Correct answer: Contact FDA MedWatch, providing all available product details; FDA will investigate the manufacturer
Reports can and should be filed even when manufacturer information is incomplete; the FDA has investigative authority to identify the manufacturer.
Question 5: A lactation consultant employed by a medical device company that sells electric breast pumps is REQUIRED to report serious device-related injuries within how many days under 21 CFR Part 803?
- 30 days for all events
- 5 days for events requiring immediate remediation; 30 days for others (Correct answer)
- 90 days
- Only when the injury results in permanent disability
Correct answer: 5 days for events requiring immediate remediation; 30 days for others
Under 21 CFR Part 803, device manufacturers must report events requiring immediate remediation within 5 working days and other serious events within 30 days.
Question 6: A breastfeeding mother is enrolled in a hospital quality improvement (QI) project—not an IRB-approved research study—and suffers an adverse event. Adverse event reporting obligations in this context fall under:
- Federal research regulations (45 CFR 46) because she is a study subject
- Hospital policy and state regulations, since QI is not federally regulated research (Correct answer)
- FDA IND regulations exclusively
- No reporting is required because QI projects are exempt from all oversight
Correct answer: Hospital policy and state regulations, since QI is not federally regulated research
QI projects are generally not subject to federal human subjects research regulations; reporting obligations are governed by hospital policy and applicable state laws.
Question 7: An infant in the NICU develops necrotizing enterocolitis (NEC) potentially linked to formula given when pasteurized donor milk was unavailable. The lactation consultant's documentation role includes:
- Avoiding documentation to prevent liability
- Accurately recording feeding history, timing of formula introduction, and clinical course to support root cause analysis (Correct answer)
- Reporting directly to the formula manufacturer and bypassing hospital risk management
- Documenting only if the formula recall notice has already been issued
Correct answer: Accurately recording feeding history, timing of formula introduction, and clinical course to support root cause analysis
Accurate, thorough documentation of feeding history and clinical events is essential for root cause analysis and supports internal review and potential regulatory reporting.
Certified Lactation Specialist Adverse Event Reporting 3
A breastfeeding mother experienced severe sedation after taking an herbal galactagogue supplement.
Since herbal supplements are regulated as dietary supplements, the adverse event should be reported to: